Japan Approves World’s First iPS Cell Medical Therapies
The Japanese Ministry of Health, Labor, and Welfare has authorized the world’s first commercial treatments utilizing induced pluripotent stem (iPS) cells, signifying a revolutionary shift in regenerative medicine. These landmark approvals target severe heart failure…











